S

Sugi Holdings Co Ltd
TSE:7649

Watchlist Manager
Sugi Holdings Co Ltd
TSE:7649
Watchlist
Price: 3 599 JPY 0.19% Market Closed
Market Cap: 683.8B JPY

Sugi Holdings Co Ltd
Net Income (Common)

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
TTM
|
See Also

Sugi Holdings Co Ltd
Net Income (Common) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Income (Common) CAGR 3Y CAGR 5Y CAGR 10Y
S
Sugi Holdings Co Ltd
TSE:7649
Net Income (Common)
ÂĄ41.2B
CAGR 3-Years
31%
CAGR 5-Years
13%
CAGR 10-Years
12%
Sundrug Co Ltd
TSE:9989
Net Income (Common)
ÂĄ31.7B
CAGR 3-Years
10%
CAGR 5-Years
6%
CAGR 10-Years
5%
Tsuruha Holdings Inc
TSE:3391
Net Income (Common)
ÂĄ28.6B
CAGR 3-Years
10%
CAGR 5-Years
0%
CAGR 10-Years
4%
Welcia Holdings Co Ltd
TSE:3141
Net Income (Common)
ÂĄ19.2B
CAGR 3-Years
-12%
CAGR 5-Years
-7%
CAGR 10-Years
9%
MatsukiyoCocokara & Co
TSE:3088
Net Income (Common)
ÂĄ55.9B
CAGR 3-Years
14%
CAGR 5-Years
19%
CAGR 10-Years
15%
Cosmos Pharmaceutical Corp
TSE:3349
Net Income (Common)
ÂĄ31B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
10%
No Stocks Found

Sugi Holdings Co Ltd
Glance View

Market Cap
651.3B JPY
Industry
Retail

In the bustling realm of Japan's retail sector, Sugi Holdings Co., Ltd. has carved out a formidable presence, quietly steering the ship of healthcare-focused retailing. Established in 1976 and headquartered in Aichi Prefecture, the company operates an extensive network of pharmacies and drugstores under the Sugi Pharmacy, Japan Co., Ltd., and Japan Wellness segments. With its core focus on pharmaceuticals, cosmetics, and daily essentials, Sugi Holdings has adeptly woven itself into the fabric of everyday life for many Japanese consumers. The company strategically places its outlets in residential areas, enabling easy access and convenience, which has proven instrumental in capturing a loyal customer base. Its business model hinges on the dual approach of brick-and-mortar stores complemented by an online presence, where e-commerce facilitates a broader reach while maintaining a personal touch through storefront interactions. The engine that propels Sugi Holdings' revenue generation is its diversified product range, which spans prescription drugs, healthcare products, and an assortment of consumer goods. This diversity orchestrates a steady, reliable cash flow, largely buffered by the recurring nature of pharmaceutical sales. In addition to retail, they offer in-home medical care services, catering to an aging population—a demographic with growing healthcare needs. The company's business acumen is reflected in its adept supply chain management and strategic pricing, which enhance both operational efficiency and competitive positioning. By embracing digital tools and data analytics to better understand consumer behavior, Sugi Holdings continues to refine its offerings, ensuring sustainable growth in a dynamic retail landscape.

Intrinsic Value
3 746.28 JPY
Undervaluation 4%
Intrinsic Value
Price
S

See Also

What is Sugi Holdings Co Ltd's Net Income (Common)?
Net Income (Common)
41.2B JPY

Based on the financial report for Aug 31, 2025, Sugi Holdings Co Ltd's Net Income (Common) amounts to 41.2B JPY.

What is Sugi Holdings Co Ltd's Net Income (Common) growth rate?
Net Income (Common) CAGR 10Y
12%

Over the last year, the Net Income (Common) growth was 66%. The average annual Net Income (Common) growth rates for Sugi Holdings Co Ltd have been 31% over the past three years , 13% over the past five years , and 12% over the past ten years .

Back to Top